Chapter 1. Research Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Service
1.2.2. End Use
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased Database
1.4.2. Internal Database
1.4.3. Secondary Sources
1.4.4. Primary Research
1.5. Information Or Data Analysis
1.5.1. Data Analysis Models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity Flow Analysis
1.7.2. Top-Down Analysis
1.7.3. Bottom-Up Approach
1.7.4. Multivariate Analysis
1.8. List of Secondary Sources
1.9. List of Abbreviations
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Investigational New Drug CDMO Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Increasing outsourcing services by pharmaceutical companies
3.2.1.2. Rising investment in R&D
3.2.1.3. Growing pharmaceutical industry
3.2.1.4. Stringent regulatory requirements
3.2.2. Market Restraint Analysis
3.2.2.1. Compliance issues while outsourcing
3.2.2.2. Changing scenario in developing countries
3.3. Technology Landscape
3.4. Pricing Model Analysis
3.5. Tariff Impact Analysis
3.6. Value Chain Analysis
3.6.1. Supply Trends
3.6.2. Demand Trends
3.7. Market Analysis Tools
3.7.1. Porter’s Five Force Analysis
3.7.2. PESTEL by SWOT Analysis
Chapter 4. Investigational New Drug CDMO Market: Service Estimates & Trend Analysis
4.1. Investigational New Drug CDMO Market, by Service: Segment Dashboard
4.2. Investigational New Drug CDMO Market, by Service: Movement Analysis
4.3. Investigational New Drug CDMO Market Estimates & Forecasts, by Service, 2021-2033 (USD Million)
4.4. Contract Development
4.4.1. Contract Development Market Estimates and Forecasts, 2021-2033 (USD Million)
4.4.2. Small Molecule
4.4.2.1. Small Molecule Market Estimates and Forecasts, 2021-2033 (USD Million)
4.4.2.2. Bioanalysis and DMPK Studies
4.4.2.2.1. Bioanalysis and DMPK Studies Market Estimates and Forecasts, 2021-2033 (USD Million)
4.4.2.3. Toxicology Testing
4.4.2.3.1. Toxicology Testing Market Estimates and Forecasts, 2021-2033 (USD Million)
4.4.2.4. Pathology and Safety Pharmacology Studies
4.4.2.4.1. Pathology and Safety Pharmacology Studies Market Estimates and Forecasts, 2021-2033 (USD Million)
4.4.2.5. Drug Substance Development
4.4.2.5.1. Drug Substance Development Market Estimates and Forecasts, 2021-2033 (USD Million)
4.4.2.5.2. Synthetic Route Development
4.4.2.5.2.1. Synthetic Route Development Market Estimates and Forecasts, 2021-2033 (USD Million)
4.4.2.5.3. Process Development
4.4.2.5.3.1. Process Development Market Estimates and Forecasts, 2021-2033 (USD Million)
4.4.2.5.4. Form Selection Crystallization Process Development
4.4.2.5.4.1. Form Selection Crystallization Process Development Market Estimates and Forecasts, 2021-2033 (USD Million)
4.4.2.5.5. Scale-up of Drug Substance
4.4.2.5.5.1. Scale-up of Drug Substance Market Estimates and Forecasts, 2021-2033 (USD Million)
4.4.2.6. Formulation Development
4.4.2.6.1. Formulation Development Market Estimates and Forecasts, 2021-2033 (USD Million)
4.4.2.6.2. Pre Formulation
4.4.2.6.2.1. Pre Formulation Market Estimates and Forecasts, 2021-2033 (USD Million)
4.4.2.6.3. Preclinical Formulation Selection
4.4.2.6.3.1. Preclinical Formulation Selection Market Estimates and Forecasts, 2021-2033 (USD Million)
4.4.2.6.4. First in Man Formulation/ Process Development
4.4.2.6.4.1. First in Man Formulation/ Process Development Market Estimates and Forecasts, 2021-2033 (USD Million)
4.4.2.7. Analytical & Quality Services
4.4.2.7.1. Analytical & Quality Services Market Estimates and Forecasts, 2021-2033 (USD Million)
4.4.2.7.2. Analytical Method Development / Validation
4.4.2.7.2.1. Analytical Method Development / Validation Market Estimates and Forecasts, 2021-2033 (USD Million)
4.4.2.7.3. Release Testing of Drug Substance and Drug Product
4.4.2.7.3.1. Release Testing of Drug Substance and Drug Product Market Estimates and Forecasts, 2021-2033 (USD Million)
4.4.2.7.4. Formal Stability of Drug Substance and Drug Product
4.4.2.7.4.1. Formal Stability of Drug Substance and Drug Product Market Estimates and Forecasts, 2021-2033 (USD Million)
4.4.2.8. Process Optimization
4.4.2.8.1. Process Optimization Market Estimates and Forecasts, 2021-2033 (USD Million)
4.4.2.8.2. Work Up Purification Steps
4.4.2.8.2.1. Work Up Purification Steps Market Estimates and Forecasts, 2021-2033 (USD Million)
4.4.2.8.3. Telescoping & Process Refining
4.4.2.8.3.1. Telescoping & Process Refining Market Estimates and Forecasts, 2021-2033 (USD Million)
4.4.2.8.4. Initial Optimization
4.4.2.8.4.1. Initial Optimization Market Estimates and Forecasts, 2021-2033 (USD Million)
4.4.3. Large Molecule
4.4.3.1. Large Molecule Market Estimates and Forecasts, 2021-2033 (USD Million)
4.4.3.2. Cell Line Development
4.4.3.2.1. Cell Line Development Market Estimates and Forecasts, 2021-2033 (USD Million)
4.4.3.3. Process Development
4.4.3.3.1. Process Development Market Estimates and Forecasts, 2021-2033 (USD Million)
4.4.3.3.2. Upstream
4.4.3.3.2.1. Upstream Market Estimates and Forecasts, 2021-2033 (USD Million)
4.4.3.3.2.2. Microbial
4.4.3.3.2.2.1. Microbial Market Estimates and Forecasts, 2021-2033 (USD Million)
4.4.3.3.2.3. Mammalian
4.4.3.3.2.3.1. Mammalian Market Estimates and Forecasts, 2021-2033 (USD Million)
4.4.3.3.2.4. Others
4.4.3.3.2.4.1. Others Market Estimates and Forecasts, 2021-2033 (USD Million)
4.4.3.3.3. Downstream
4.4.3.3.3.1. Downstream Market Estimates and Forecasts, 2021-2033 (USD Million)
4.4.3.3.3.2. MABs
4.4.3.3.3.2.1. MABs Market Estimates and Forecasts, 2021-2033 (USD Million)
4.4.3.3.3.3. Recombinant Proteins
4.4.3.3.3.3.1. Recombinant Proteins Market Estimates and Forecasts, 2021-2033 (USD Million)
4.4.3.3.3.4. Others
4.4.3.3.3.4.1. Others Market Estimates and Forecasts, 2021-2033 (USD Million)
4.5. Contract Development
4.5.1. Contract Development Market Estimates and Forecasts, 2021-2033 (USD Million)
4.5.2. Small Molecule
4.5.2.1. Small Molecule Market Estimates and Forecasts, 2021-2033 (USD Million)
4.5.2.2. Oral Solids
4.5.2.2.1. Oral Solids Market Estimates and Forecasts, 2021-2033 (USD Million)
4.5.2.3. Semi-Solids
4.5.2.3.1. Semi-Solids Market Estimates and Forecasts, 2021-2033 (USD Million)
4.5.2.4. Liquids & Injectables
4.5.2.4.1. Liquids & Injectables Market Estimates and Forecasts, 2021-2033 (USD Million)
4.5.2.5. Others
4.5.2.5.1. Others Market Estimates and Forecasts, 2021-2033 (USD Million)
4.5.3. Large Molecule
4.5.3.1. Large Molecule Market Estimates and Forecasts, 2021-2033 (USD Million)
4.5.3.2. MABs
4.5.3.2.1. MABs Market Estimates and Forecasts, 2021-2033 (USD Million)
4.5.3.3. Recombinant Proteins
4.5.3.3.1. Recombinant Proteins Market Estimates and Forecasts, 2021-2033 (USD Million)
4.5.3.4. Others
4.5.3.4.1. Others Market Estimates and Forecasts, 2021-2033 (USD Million)
Chapter 5. Investigational New Drug CDMO Market: by End Use Estimates & Trend Analysis
5.1. Investigational New Drug CDMO Market, by End Use: Segment Dashboard
5.2. Investigational New Drug CDMO Market, by End Use: Movement Analysis
5.3. Investigational New Drug CDMO Market Estimates & Forecasts, by End Use, 2021-2033 (USD Million)
5.4. Pharmaceutical Companies
5.4.1. Pharmaceutical Companies Market Estimates and Forecasts, 2021-2033 (USD Million)
5.5. Biotech Companies
5.5.1. Biotech Companies Market Estimates and Forecasts, 2021-2033 (USD Million)
5.6. Others
5.6.1. Others Market Estimates and Forecasts, 2021-2033 (USD Million)
Chapter 6. Investigational New Drug CDMO Market: Regional Estimates & Trend Analysis
6.1. Regional Market Dashboard
6.2. Regional Market Share Analysis, 2024 & 2033
6.3. North America
6.3.1. North America Market Estimates and Forecasts, 2021-2033 (USD Million)
6.3.2. U.S
6.3.2.1. Key Country Dynamics
6.3.2.2. Competitive Scenario
6.3.2.3. Regulatory Framework
6.3.2.4. U.S. Market Estimates and Forecasts, 2021-2033 (USD Million)
6.3.3. Canada
6.3.3.1. Key Country Dynamics
6.3.3.2. Competitive Scenario
6.3.3.3. Regulatory Framework
6.3.3.4. Canada Market Estimates and Forecasts, 2021-2033 (USD Million)
6.3.4. Mexico
6.3.4.1. Key Country Dynamics
6.3.4.2. Competitive Scenario
6.3.4.3. Regulatory Framework
6.3.4.4. Mexico Market Estimates and Forecasts, 2021-2033 (USD Million)
6.4. Europe
6.4.1. Europe Market Estimates and Forecasts, 2021-2033 (USD Million)
6.4.2. UK
6.4.2.1. Key Country Dynamics
6.4.2.2. Competitive Scenario
6.4.2.3. Regulatory Framework
6.4.2.4. UK Market Estimates and Forecasts, 2021-2033 (USD Million)
6.4.3. Germany
6.4.3.1. Key Country Dynamics
6.4.3.2. Competitive Scenario
6.4.3.3. Regulatory Framework
6.4.3.4. Germany Market Estimates and Forecasts, 2021-2033 (USD Million)
6.4.4. France
6.4.4.1. Key Country Dynamics
6.4.4.2. Competitive Scenario
6.4.4.3. Regulatory Framework
6.4.4.4. France Market Estimates and Forecasts, 2021-2033 (USD Million)
6.4.5. Italy
6.4.5.1. Key Country Dynamics
6.4.5.2. Competitive Scenario
6.4.5.3. Regulatory Framework
6.4.5.4. Italy Market Estimates and Forecasts, 2021-2033 (USD Million)
6.4.6. Spain
6.4.6.1. Key Country Dynamics
6.4.6.2. Competitive Scenario
6.4.6.3. Regulatory Framework
6.4.6.4. Spain Market Estimates and Forecasts, 2021-2033 (USD Million)
6.4.7. Denmark
6.4.7.1. Key Country Dynamics
6.4.7.2. Competitive Scenario
6.4.7.3. Regulatory Framework
6.4.7.4. Denmark Market Estimates and Forecasts, 2021-2033 (USD Million)
6.4.8. Sweden
6.4.8.1. Key Country Dynamics
6.4.8.2. Competitive Scenario
6.4.8.3. Regulatory Framework
6.4.8.4. Sweden Market Estimates and Forecasts, 2021-2033 (USD Million)
6.4.9. Norway
6.4.9.1. Key Country Dynamics
6.4.9.2. Competitive Scenario
6.4.9.3. Regulatory Framework
6.4.9.4. Norway Market Estimates and Forecasts, 2021-2033 (USD Million)
6.5. Asia Pacific
6.5.1. Asia Pacific Market Estimates and Forecasts, 2021-2033 (USD Million)
6.5.2. Japan
6.5.2.1. Key Country Dynamics
6.5.2.2. Competitive Scenario
6.5.2.3. Regulatory Framework
6.5.2.4. Japan Market Estimates and Forecasts, 2021-2033 (USD Million)
6.5.3. China
6.5.3.1. Key Country Dynamics
6.5.3.2. Competitive Scenario
6.5.3.3. Regulatory Framework
6.5.3.4. China Market Estimates and Forecasts, 2021-2033 (USD Million)
6.5.4. India
6.5.4.1. Key Country Dynamics
6.5.4.2. Competitive Scenario
6.5.4.3. Regulatory Framework
6.5.4.4. India Market Estimates and Forecasts, 2021-2033 (USD Million)
6.5.5. Australia
6.5.5.1. Key Country Dynamics
6.5.5.2. Competitive Scenario
6.5.5.3. Regulatory Framework
6.5.5.4. Australia Market Estimates and Forecasts, 2021-2033 (USD Million)
6.5.6. Thailand
6.5.6.1. Key Country Dynamics
6.5.6.2. Competitive Scenario
6.5.6.3. Regulatory Framework
6.5.6.4. Thailand Market Estimates and Forecasts, 2021-2033 (USD Million)
6.5.7. South Korea
6.5.7.1. Key Country Dynamics
6.5.7.2. Competitive Scenario
6.5.7.3. Regulatory Framework
6.5.7.4. South Korea Market Estimates and Forecasts, 2021-2033 (USD Million)
6.6. Latin America
6.6.1. Latin America Market Estimates and Forecasts, 2021-2033 (USD Million)
6.6.2. Brazil
6.6.2.1. Key Country Dynamics
6.6.2.2. Competitive Scenario
6.6.2.3. Regulatory Framework
6.6.2.4. Brazil Market Estimates and Forecasts, 2021-2033 (USD Million)
6.6.3. Argentina
6.6.3.1. Key Country Dynamics
6.6.3.2. Competitive Scenario
6.6.3.3. Regulatory Framework
6.6.3.4. Argentina Market Estimates and Forecasts, 2021-2033 (USD Million)
6.7. MEA
6.7.1. MEA Market Estimates and Forecasts, 2021-2033 (USD Million)
6.7.2. South Africa
6.7.2.1. Key Country Dynamics
6.7.2.2. Competitive Scenario
6.7.2.3. Regulatory Framework
6.7.2.4. South Africa Market Estimates and Forecasts, 2021-2033 (USD Million)
6.7.3. UAE
6.7.3.1. Key Country Dynamics
6.7.3.2. Competitive Scenario
6.7.3.3. Regulatory Framework
6.7.3.4. UAE Market Estimates and Forecasts, 2021-2033 (USD Million)
6.7.4. Saudi Arabia
6.7.4.1. Key Country Dynamics
6.7.4.2. Competitive Scenario
6.7.4.3. Regulatory Framework
6.7.4.4. Saudi Arabia Market Estimates and Forecasts, 2021-2033 (USD Million)
6.7.5. Kuwait
6.7.5.1. Key Country Dynamics
6.7.5.2. Competitive Scenario
6.7.5.3. Regulatory Framework
6.7.5.4. Kuwait Market Estimates and Forecasts, 2021-2033 (USD Million)
6.7.6. Qatar
6.7.6.1. Key Country Dynamics
6.7.6.2. Competitive Scenario
6.7.6.3. Regulatory Framework
6.7.6.4. Qatar Market Estimates and Forecasts, 2021-2033 (USD Million)
6.7.7. Oman
6.7.7.1. Key Country Dynamics
6.7.7.2. Competitive Scenario
6.7.7.3. Regulatory Framework
6.7.7.4. Oman Market Estimates and Forecasts, 2021-2033 (USD Million)
Chapter 7. Competitive Landscape
7.1. Key Participant Categorization
7.1.1. Market Leaders
7.1.2. Emerging Players
7.2. Market Share/Assessment Analysis, 2024 (Heat Map Analysis)
7.3. Company Profiles
7.3.1. Catalent, Inc.
7.3.1.1. Company Overview
7.3.1.2. Financial Performance
7.3.1.3. Service Benchmarking
7.3.1.4. Strategic Initiatives
7.3.2. Lonza
7.3.2.1. Company Overview
7.3.2.2. Financial Performance
7.3.2.3. Service Benchmarking
7.3.2.4. Strategic Initiatives
7.3.3. Recipharm AB
7.3.3.1. Company Overview
7.3.3.2. Financial Performance
7.3.3.3. Service Benchmarking
7.3.3.4. Strategic Initiatives
7.3.4. Siegfried Holding AG
7.3.4.1. Company Overview
7.3.4.2. Financial Performance
7.3.4.3. Service Benchmarking
7.3.4.4. Strategic Initiatives
7.3.5. Patheon Inc.
7.3.5.1. Company Overview
7.3.5.2. Financial Performance
7.3.5.3. Service Benchmarking
7.3.5.4. Strategic Initiatives
7.3.6. Covance
7.3.6.1. Company Overview
7.3.6.2. Financial Performance
7.3.6.3. Service Benchmarking
7.3.6.4. Strategic Initiatives
7.3.7. IQVIA Holdings Inc.
7.3.7.1. Company Overview
7.3.7.2. Financial Performance
7.3.7.3. Service Benchmarking
7.3.7.4. Strategic Initiatives
7.3.8. Cambrex Corporation
7.3.8.1. Company Overview
7.3.8.2. Financial Performance
7.3.8.3. Service Benchmarking
7.3.8.4. Strategic Initiatives
7.3.9. Charles River Laboratories International, Inc.
7.3.9.1. Company Overview
7.3.9.2. Financial Performance
7.3.9.3. Service Benchmarking
7.3.9.4. Strategic Initiatives
7.3.10. Syneos Health
7.3.10.1. Company Overview
7.3.10.2. Financial Performance
7.3.10.3. Service Benchmarking
7.3.10.4. Strategic Initiatives
7.3.11. Syngene International
7.3.11.1. Company Overview
7.3.11.2. Financial Performance
7.3.11.3. Service Benchmarking
7.3.11.4. Strategic Initiatives
7.3.12. Jubilant Pharmova
7.3.12.1. Company Overview
7.3.12.2. Financial Performance
7.3.12.3. Service Benchmarking
7.3.12.4. Strategic Initiatives
7.3.13. Piramal Pharma Solutions
7.3.13.1. Company Overview
7.3.13.2. Financial Performance
7.3.13.3. Service Benchmarking
7.3.13.4. Strategic Initiatives
7.3.14. Dr. Reddy’s CPS
7.3.14.1. Company Overview
7.3.14.2. Financial Performance
7.3.14.3. Service Benchmarking
7.3.14.4. Strategic Initiatives
7.3.15. Dishman Carbogen Amcis
7.3.15.1. Company Overview
7.3.15.2. Financial Performance
7.3.15.3. Service Benchmarking
7.3.15.4. Strategic Initiatives
7.3.16. Biocon Biologics
7.3.16.1. Company Overview
7.3.16.2. Financial Performance
7.3.16.3. Service Benchmarking
7.3.16.4. Strategic Initiatives
7.3.17. Laurus Labs
7.3.17.1. Company Overview
7.3.17.2. Financial Performance
7.3.17.3. Service Benchmarking
7.3.17.4. Strategic Initiatives
List of Tables
Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Global Investigational New Drug CDMO Market Estimates and Forecasts, by Service, 2021-2033 (USD Million)
Table 4 Global Investigational New Drug CDMO Market Estimates and Forecasts, by End Use, 2021-2033 (USD Million)
Table 5 Global Investigational New Drug CDMO Market Estimates and Forecasts, by Region, 2021-2033 (USD Million)
Table 6 North America Investigational New Drug CDMO Market Estimates and Forecasts, by Country, 2021-2033 (USD Million)
Table 7 North America Investigational New Drug CDMO Market Estimates and Forecasts, by Service, 2021-2033 (USD Million)
Table 8 North America Investigational New Drug CDMO Market Estimates and Forecasts, by End Use, 2021-2033 (USD Million)
Table 9 US Investigational New Drug CDMO Market Estimates and Forecasts, by Service, 2021-2033 (USD Million)
Table 10 US Investigational New Drug CDMO Market Estimates and Forecasts, by End Use, 2021-2033 (USD Million)
Table 11 US Investigational New Drug CDMO Market Estimates and Forecasts, by Therapeutics Area, 2021-2033 (USD Million)
Table 12 Canada Investigational New Drug CDMO Market Estimates and Forecasts, by Service, 2021-2033 (USD Million)
Table 13 Canada Investigational New Drug CDMO Market Estimates and Forecasts, by End Use, 2021-2033 (USD Million)
Table 14 Mexico Investigational New Drug CDMO Market Estimates and Forecasts, by Service, 2021-2033 (USD Million)
Table 15 Mexico Investigational New Drug CDMO Market Estimates and Forecasts, by End Use, 2021-2033 (USD Million)
Table 16 Europe Investigational New Drug CDMO Market Estimates and Forecasts, by Country, 2021-2033 (USD Million)
Table 17 Europe Investigational New Drug CDMO Market Estimates and Forecasts, by Service, 2021-2033 (USD Million)
Table 18 Europe Investigational New Drug CDMO Market Estimates and Forecasts, by End Use, 2021-2033 (USD Million)
Table 19 UK Investigational New Drug CDMO Market Estimates and Forecasts, by Service, 2021-2033 (USD Million)
Table 20 UK Investigational New Drug CDMO Market Estimates and Forecasts, by End Use, 2021-2033 (USD Million)
Table 21 Germany Investigational New Drug CDMO Market Estimates and Forecasts, by Service, 2021-2033 (USD Million)
Table 22 Germany Investigational New Drug CDMO Market Estimates and Forecasts, by End Use, 2021-2033 (USD Million)
Table 23 France Investigational New Drug CDMO Market Estimates and Forecasts, by Service, 2021-2033 (USD Million)
Table 24 France Investigational New Drug CDMO Market Estimates and Forecasts, by End Use, 2021-2033 (USD Million)
Table 25 Italy Investigational New Drug CDMO Market Estimates and Forecasts, by Service, 2021-2033 (USD Million)
Table 26 Italy Investigational New Drug CDMO Market Estimates and Forecasts, by End Use, 2021-2033 (USD Million)
Table 27 Spain Investigational New Drug CDMO Market Estimates and Forecasts, by Service, 2021-2033 (USD Million)
Table 28 Spain Investigational New Drug CDMO Market Estimates and Forecasts, by End Use, 2021-2033 (USD Million)
Table 29 Denmark Investigational New Drug CDMO Market Estimates and Forecasts, by Service, 2021-2033 (USD Million)
Table 30 Denmark Investigational New Drug CDMO Market Estimates and Forecasts, by End Use, 2021-2033 (USD Million)
Table 31 Sweden Investigational New Drug CDMO Market Estimates and Forecasts, by Service, 2021-2033 (USD Million)
Table 32 Sweden Investigational New Drug CDMO Market Estimates and Forecasts, by End Use, 2021-2033 (USD Million)
Table 33 Norway Investigational New Drug CDMO Market Estimates and Forecasts, by Service, 2021-2033 (USD Million)
Table 34 Norway Investigational New Drug CDMO Market Estimates and Forecasts, by End Use, 2021-2033 (USD Million)
Table 35 Asia-Pacific Investigational New Drug CDMO Market Estimates and Forecasts, by Country, 2021-2033 (USD Million)
Table 36 Asia-Pacific Investigational New Drug CDMO Market Estimates and Forecasts, by Service, 2021-2033 (USD Million)
Table 37 Asia-Pacific Investigational New Drug CDMO Market Estimates and Forecasts, by End Use, 2021-2033 (USD Million)
Table 38 Japan Investigational New Drug CDMO Market Estimates and Forecasts, by Service, 2021-2033 (USD Million)
Table 39 Japan Investigational New Drug CDMO Market Estimates and Forecasts, by End Use, 2021-2033 (USD Million)
Table 40 China Investigational New Drug CDMO Market Estimates and Forecasts, by Service, 2021-2033 (USD Million)
Table 41 China Investigational New Drug CDMO Market Estimates and Forecasts, by End Use, 2021-2033 (USD Million)
Table 42 India Investigational New Drug CDMO Market Estimates and Forecasts, by Service, 2021-2033 (USD Million)
Table 43 India Investigational New Drug CDMO Market Estimates and Forecasts, by End Use, 2021-2033 (USD Million)
Table 44 Australia Investigational New Drug CDMO Market Estimates and Forecasts, by Service, 2021-2033 (USD Million)
Table 45 Australia Investigational New Drug CDMO Market Estimates and Forecasts, by End Use, 2021-2033 (USD Million)
Table 46 Thailand Investigational New Drug CDMO Market Estimates and Forecasts, by Service, 2021-2033 (USD Million)
Table 47 Thailand Investigational New Drug CDMO Market Estimates and Forecasts, by End Use, 2021-2033 (USD Million)
Table 48 South Korea Investigational New Drug CDMO Market Estimates and Forecasts, by Service, 2021-2033 (USD Million)
Table 49 South Korea Investigational New Drug CDMO Market Estimates and Forecasts, by End Use, 2021-2033 (USD Million)
Table 50 Latin America Investigational New Drug CDMO Market Estimates and Forecasts, by Country, 2021-2033 (USD Million)
Table 51 Latin America Investigational New Drug CDMO Market Estimates and Forecasts, by Service, 2021-2033 (USD Million)
Table 52 Latin America Investigational New Drug CDMO Market Estimates and Forecasts, by End Use, 2021-2033 (USD Million)
Table 53 Brazil Investigational New Drug CDMO Market Estimates and Forecasts, by Service, 2021-2033 (USD Million)
Table 54 Brazil Investigational New Drug CDMO Market Estimates and Forecasts, by End Use, 2021-2033 (USD Million)
Table 55 Argentina Investigational New Drug CDMO Market Estimates and Forecasts, by Service, 2021-2033 (USD Million)
Table 56 Argentina Investigational New Drug CDMO Market Estimates and Forecasts, by End Use, 2021-2033 (USD Million)
Table 57 Middle East & Africa Investigational New Drug CDMO Market Estimates and Forecasts, by Country, 2021-2033 (USD Million)
Table 58 Middle East & Africa Investigational New Drug CDMO Market Estimates and Forecasts, by Service, 2021-2033 (USD Million)
Table 59 Middle East & Africa Investigational New Drug CDMO Market Estimates and Forecasts, by End Use, 2021-2033 (USD Million)
Table 60 South Africa Investigational New Drug CDMO Market Estimates and Forecasts, by Service, 2021-2033 (USD Million)
Table 61 South Africa Investigational New Drug CDMO Market Estimates and Forecasts, by End Use, 2021-2033 (USD Million)
Table 62 UAE Investigational New Drug CDMO Market Estimates and Forecasts, by Service, 2021-2033 (USD Million)
Table 63 UAE Investigational New Drug CDMO Market Estimates and Forecasts, by End Use, 2021-2033 (USD Million)
Table 64 Saudi Arabia Investigational New Drug CDMO Market Estimates and Forecasts, by Service, 2021-2033 (USD Million)
Table 65 Saudi Arabia Investigational New Drug CDMO Market Estimates and Forecasts, by End Use, 2021-2033 (USD Million)
Table 66 Kuwait Investigational New Drug CDMO Market Estimates and Forecasts, by Service, 2021-2033 (USD Million)
Table 67 Kuwait Investigational New Drug CDMO Market Estimates and Forecasts, by End Use, 2021-2033 (USD Million)
Table 68 Qatar Investigational New Drug CDMO Market Estimates and Forecasts, by Service, 2021-2033 (USD Million)
Table 69 Qatar Investigational New Drug CDMO Market Estimates and Forecasts, by End Use, 2021-2033 (USD Million)
Table 70 Oman Investigational New Drug CDMO Market Estimates and Forecasts, by Service, 2021-2033 (USD Million)
Table 71 Oman Investigational New Drug CDMO Market Estimates and Forecasts, by End Use, 2021-2033 (USD Million)
List of Figures
Figure 1 Market research process
Figure 2 Information procurement
Figure 3 Primary research pattern
Figure 4 Market research approaches
Figure 5 Market formulation & validation
Figure 6 Commodity flow analysis
Figure 7 Value-chain-based sizing & forecasting
Figure 8 QFD model sizing & forecasting
Figure 9 Bottom-up approach
Figure 10 Market snapshot
Figure 11 Segment snapshot 1
Figure 12 Segment snapshot 2
Figure 13 Competitive landscape snapshot
Figure 14 Parent market outlook, 2024 (USD Billion)
Figure 15 Ancillary market outlook, 2024 (USD Billion)
Figure 16 Investigational New Drug CDMO Market Dynamics
Figure 17 Porter’s five forces analysis
Figure 18 PESTEL analysis
Figure 19 Investigational New Drug CDMO Market: Service outlook and key takeaways
Figure 20 Investigational New Drug CDMO Market: Service movement analysis
Figure 21 Contract Development Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 22 Small Molecule Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 23 Bioanalysis and DMPK Studies Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 24 Toxicology Testing Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 25 Pathology and Safety Pharmacology Studies Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 26 Drug Substance Development Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 27 Synthetic Route Development Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 28 Process Development Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 29 Form Selection Crystallization Process Development Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 30 Scale-up of Drug Substance Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 31 Formulation Development Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 32 Pre Formulation Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 33 Preclinical Formulation Selection Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 34 First In Man Formulation/ Process Development Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 35 Analytical & Quality Services Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 36 Analytical Method Development / Validation Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 37 Release Testing of Drug Substance and Drug Product Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 38 Formal Stability of Drug Substance and Drug Product Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 39 Process Optimization Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 40 Work Up Purification Steps Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 41 Telescoping & Process Refining Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 42 Initial Optimization Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 43 Large Molecule Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 44 Cell Line Development Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 45 Process Development Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 46 Upstream Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 47 Microbial Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 48 Mammalian Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 49 Others Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 50 Downstream Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 51 MABs Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 52 Recombinant Proteins Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 53 Others Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 54 Contract Manufacturing Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 55 Small Molecule Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 56 Oral Solids Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 57 Semi-Solids Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 58 Liquids & Injectables Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 59 Others Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 60 Large Molecule Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 61 MABs Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 62 Recombinant Proteins Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 63 Others Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 64 Investigational New Drug CDMO Market: End Use outlook and key takeaways
Figure 65 Investigational New Drug CDMO Market: End Use movement analysis
Figure 66 Pharmaceutical Companies Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 67 Biotech Companies Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 68 Others Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 69 Regional Marketplace: Key Takeaways
Figure 70 North America Investigational New Drug CDMO Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 71 Key country dynamics
Figure 72 U.S. Investigational New Drug CDMO Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 73 Key country dynamics
Figure 74 Canada Investigational New Drug CDMO Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 75 Key country dynamics
Figure 76 Mexico Investigational New Drug CDMO Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 77 Europe Investigational New Drug CDMO Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 78 Key country dynamics
Figure 79 UK Investigational New Drug CDMO Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 80 Key country dynamics
Figure 81 Germany Investigational New Drug CDMO Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 82 Key country dynamics
Figure 83 France Investigational New Drug CDMO Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 84 Key country dynamics
Figure 85 Italy Investigational New Drug CDMO Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 86 Key country dynamics
Figure 87 Spain Investigational New Drug CDMO Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 88 Key country dynamics
Figure 89 Denmark Investigational New Drug CDMO Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 90 Key country dynamics
Figure 91 Sweden Investigational New Drug CDMO Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 92 Key country dynamics
Figure 93 Norway Investigational New Drug CDMO Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 94 Asia-Pacific Investigational New Drug CDMO Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 95 Key country dynamics
Figure 96 Japan Investigational New Drug CDMO Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 97 Key country dynamics
Figure 98 China Investigational New Drug CDMO Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 99 Key country dynamics
Figure 100 India Investigational New Drug CDMO Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 101 Key country dynamics
Figure 102 Australia Investigational New Drug CDMO Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 103 Key country dynamics
Figure 104 Thailand Investigational New Drug CDMO Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 105 Key country dynamics
Figure 106 South Korea Investigational New Drug CDMO Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 107 Latin America Investigational New Drug CDMO Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 108 Key country dynamics
Figure 109 Brazil Investigational New Drug CDMO Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 110 Key country dynamics
Figure 111 Argentina Investigational New Drug CDMO Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 112 MEA Investigational New Drug CDMO Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 113 Key country dynamics
Figure 114 South Africa Investigational New Drug CDMO Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 115 Key country dynamics
Figure 116 UAE Investigational New Drug CDMO Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 117 Key country dynamics
Figure 118 Saudi Arabia Investigational New Drug CDMO Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 119 Key country dynamics
Figure 120 Kuwait Investigational New Drug CDMO Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 121 Key country dynamics
Figure 122 Qatar Investigational New Drug CDMO Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 123 Key country dynamics
Figure 124 Oman Investigational New Drug CDMO Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 125 Key company categorization
Figure 126 Service heat map analysis
Figure 127 Strategic framework
